COL4A1 and cancer: Furthermore, we investigated the potential role of elevated COL4A1 expression on the modulation of the immune landscape of TME to assess the prognostic value of COL4A1 expression as a biomarker, thereby providing novel insights into immunotherapeutic avenues for better treatment of patients with cancer.